BHA‐CS: A novel cognitive composite for Alzheimer's disease and related disorders is a research paper published in Alzheimer s & Dementia Diagnosis Assessment & Disease Monitoring (2020). On theSindex it has a DataRank of 0. It has been cited 40 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
NIA NIH HHS
Grant: P30 AG010129
Alzheimer's Association
Grant: AARF‐16‐443577
National Institute on Aging
Grant: P01AG019724
National Institute of Neurological Disorders and Stroke
Grant: UG3 NS105557‐01
NIA NIH HHS
Grant: R01 AG032289
NIA NIH HHS
Grant: RF1 AG032289
NIA NIH HHS
Grant: P30 AG062422
NINDS NIH HHS
Grant: UG3 NS105557
National Institutes of Health
Grant: 1UG3NS105557-01
The UCSF Brain Health Assessment for the Detection of Cognitive Impairment Among Diverse Populations in Primary Care
National Institutes of Health
Grant: 3P30AG010129-28S1
UC Davis Alzheimer's Core Center
National Institutes of Health
Grant: 5P30AG062422-03
New Approaches to Dementia Heterogeneity
National Institutes of Health
Grant: 5P01AG019724-03
FRONTOTEMPORAL DEMENTIA: GENES, IMAGES, AND EMOTIONS
Fields of Study
Keywords
Sustainable Development Goals
Additional file 1 of Stakeholder-informed pragmatic trial protocol of the TabCAT-BHA for the detection of cognitive impairment in primary care
Additional file 1 of Stakeholder-informed pragmatic trial protocol of the TabCAT-BHA for the detection of cognitive impairment in primary care